Advertisement

Hypersalivation: update of the German S2k guideline (AWMF) in short form

  • Armin SteffenEmail author
  • Wolfgang Jost
  • Tobias Bäumer
  • Dirk Beutner
  • Sabine Degenkolb-Weyers
  • Martin Groß
  • Maria Grosheva
  • Samer Hakim
  • Kai G. Kahl
  • Rainer Laskawi
  • Rebekka Lencer
  • Jan Löhler
  • Thekla Meyners
  • Saskia Rohrbach-Volland
  • Rainer Schönweiler
  • Sara-Christina Schröder
  • Sebastian Schröder
  • Heidrun Schröter-Morasch
  • Maria Schuster
  • Susanne Steinlechner
  • Roland Urban
  • Orlando Guntinas-Lichius
Neurology and Preclinical Neurological Studies - Review Article
  • 60 Downloads

Abstract

Hypersalivation describes a relatively excessive salivary flow, which wets the patient himself and his surroundings. It may result because of insufficient oro-motor function, dysphagia, decreased central control and coordination. This update presents recent changes and innovation in the treatment of hypersalivation. Multidisciplinary diagnostic and treatment evaluation is recommended already at early stage and focus on dysphagia, saliva aspiration, and oro-motor deficiencies. Clinical screening tools and diagnostics such as fiberoptic endoscopic evaluation of swallowing generate important data on therapy selection and control. Many cases profit from swallowing therapy programmes to activate compensation mechanisms as long compliances are given. In children with hypotonic oral muscles, oral stimulation plates can induce a relevant symptom release because of the improved lip closure. The pharmacologic treatment improved for pediatric cases as glycopyrrolate fluid solution (Sialanar®) is now indicated for hypersalivation within the EU. The injection of botulinum toxin into the salivary glands has shown safe and effective results with long-lasting saliva reduction. Here, a phase III trial is completed for incobotulinum toxin A and, in the US, is indicated for the treatment of adult patients with chronic hypersalivation. Surgical treatment should be reserved for isolated cases. External radiation is judged as a safe and effective therapy when using modern 3D techniques to minimize tissue damage. Therapy effects and symptom severity have to be followed, especially in cases with underlying neurodegenerative disease.

Keywords

Hypersalivation Drooling Dysphagia Glycopyrrolate Oro-motor and oro-sensory therapy Botulinum toxin Sialorrhea 

Notes

References

  1. Abeleira MT, Pazos E, Ramos I, Outumuro M, Limeres J, Seoane-Romero J, Diniz M, Diz P (2014) Orthodontic treatment for disabled children: a survey of parents’ attitudes and overall satisfaction. BMC Oral Health 14:98CrossRefPubMedPubMedCentralGoogle Scholar
  2. Alberty J, Oelrich M, Ludwig K, Hartmann S, Stoll W (2000) Efficacy of botulinum toxin A for the treatment of upper esophageal sphincter dysfunction. Laryngoscope 110:1151–1156CrossRefPubMedGoogle Scholar
  3. American Academy for Cerebral Palsy and Development Medicine (2017) Care pathways: sialorrhea in cerebral palsy. http://www.aacpdm.org/publications/care-pathways/sialorrhea. Accessed 13 June 2018
  4. Andersen PM, Grönberg H, Franzen L, Funegård U (2001) External radiation of the parotid glands significantly reduces drooling in patients with motor neurone disease with bulbar paresis. J Neurol Sci 191:111–114CrossRefPubMedGoogle Scholar
  5. Assouline A, Levy A, Abdelnour-Mallet M, Gonzalez-Bermejo J, Lenglet T, Le Forestier N, Salachas F, Bruneteau G, Meininger V, Delanian S, Pradat PF (2014) Radiation therapy for hypersalivation: a prospective study in 50 amyotrophic lateral sclerosis patients. Int J Radiat Oncol Biol Phys 88:589–595CrossRefPubMedGoogle Scholar
  6. Bachrach SJ, Walter RS, Trzcinski K (1998) Use of glycopyrrolate and other anticholinergic medications for sialorrhea in children with cerebral palsy. Clin Pediatr (Phila) 37:485–490CrossRefGoogle Scholar
  7. Bader C, Niemann G (2010) Dysphagie bei Kindern mit Infantiler Zerebralparese—Fiberoptisch—endoskopische Befunde. Laryngorhinootologie 89:90–94CrossRefPubMedGoogle Scholar
  8. Banfi P, Ticozzi N, Lax A, Guidugli GA, Nicolini A, Silani V (2015) A review of options for treating sialorrhea in amyotrophic lateral sclerosis. Respir Care 60:446–454CrossRefPubMedGoogle Scholar
  9. Bartolome G (2014a) Aspirationsschnelltests und Klinische Schluckuntersuchung. In: Bartolome G, Schröter-Morasch H (eds) Schluckstörungen—Diagnostik und Rehabilitation, 5th edn. Elsevier, München, pp 151–171Google Scholar
  10. Bartolome G (2014b) Grundlagen der funktionellen Dysphagietherapie (FDT). In: Bartolome G, Schröter-Morasch H (eds) Schluckstörungen – Diagnostik und Rehabilitation, 5th edn. Elsevier, München, pp 261–403Google Scholar
  11. Bath PM, Scutt P, Love J, Clavé P, Cohen D, Dziewas R, Iversen HK, Ledl C, Ragab S, Soda H, Warusevitane A, Woisard V, Hamdy S, Swallowing Treatment Using Pharyngeal Electrical Stimulation (STEPS) trial investigators (2016) Pharyngeal electrical stimulation for treatment of dysphagia in subacute stroke. Stroke 47:1562–1570CrossRefPubMedPubMedCentralGoogle Scholar
  12. Becker A, Shapira J, Chaushu S (2000) Orthodontic treatment for disabled children: motivation, expectation and satisfaction. Eur J Orthod 22:151–158CrossRefPubMedGoogle Scholar
  13. Becmeur F, Schneider A, Flaum V, Klipfel C, Pierrel C, Lacreuse I (2013) Which surgery for drooling in patients with cerebral palsy ? J Pediatr Surg 48:2171–2174CrossRefPubMedGoogle Scholar
  14. Blasco PA (2002) Management of drooling: 10 years after the consortium on Drooling, 1990. Dev Med Child Neurol 44:778–781CrossRefPubMedGoogle Scholar
  15. Blasco PA, Allaire JH (1992) Drooling in the developmentally disabled: management practices and recommendations. Consortium on Drooling. Dev Med Child Neurol 34:849–862CrossRefPubMedGoogle Scholar
  16. Blasco PA, Stansbury JC (1996) Glycopyrrolate treatment of chronic drooling. Arch Pediatr Adolesc Med 150:932–935CrossRefPubMedGoogle Scholar
  17. Blissit KT, Tillery E, Latham C, Pacheco-Perez J (2014) Glycopyrrolate for treatment of clozapine-induced sialorrhea in adults. Am J Health Syst Pharm 71:1282–1287CrossRefPubMedGoogle Scholar
  18. Borg M, Hirst F (1998) The role of radiation therapy in the management of sialorrhea. Int J Radiat Oncol Biol Phys 41:1113–1119CrossRefPubMedGoogle Scholar
  19. Burkhead LM, Sapienza CM, Rosenbek JC (2007) Strength-training exercise in dysphagia rehabilitation: principles, procedures, and directions for future research. Dysphagia 22:251–265CrossRefPubMedGoogle Scholar
  20. Camp-Bruno JA, Winsberg BG, Green-Parsons AR, Abrams JP (1989) Efficacy of benztropine therapy for drooling. Dev Med Child Neurol 31:309–319CrossRefPubMedGoogle Scholar
  21. Carnaby G, Hankey GJ, Pizzi J (2006) Behavioural intervention for dysphagia in acute stroke: a randomised controlled trial. Lancet Neurol 5:31–37CrossRefPubMedGoogle Scholar
  22. Checklin M, Etty-Leal M, Iseli TA, Potter N, Fisher S, Chapman L (2015) Saliva management options for difficult-to-wean people with tracheostomy following severe acquired brain injury (ABI): a review of the literature. Brain Inj 29:1–10CrossRefPubMedGoogle Scholar
  23. Christiansen H, Wolff HA, Knauth J, Hille A, Vorwerk H, Engelke C, Rödel R, Laskawi R (2009) Radiatio: therapieoption bei therapierefraktärer Speichelfistel. HNO 57:1325–1358CrossRefPubMedGoogle Scholar
  24. Crysdale WS, White A (1989) Submandibular duct relocation for drooling: a 10-year experience with 194 patients. Otolaryngol Head Neck Surg 101:87–92CrossRefPubMedGoogle Scholar
  25. Crysdale WS, McCann C, Roske L, Joseph M, Semenuk D, Chait P (2006) Saliva control issues in the neurologically challenged. A 30 year experience in team management. Int J Pediatr Otorhinolaryngol 70:519–527CrossRefPubMedGoogle Scholar
  26. De Simone GG, Eisenchlas JH, Junin M, Pereyra F, Brizuela R (2006) Atropine drops for drooling: a randomized controlled trial. Palliat Med 20:665–671CrossRefPubMedGoogle Scholar
  27. Del Tredici K, Jost WH (2012) Gastrointestinal dysfunction in idiopathic Parkinson’s disease. Nervenarzt 83:1282–1291CrossRefPubMedGoogle Scholar
  28. Diesener P (1999) Schluckstörungen bei Kindern: Bildgebende Diagnostik mittels transnasaler Videoendoskopie. Prakt Pädiatrie 5:36–42Google Scholar
  29. Doeltgen SH, Huckabee M-L (2012) Swallowing neurorehabilitation: from the research laboratory to routine clinical application. Arch Phys Med Rehabil 93:207–213CrossRefPubMedGoogle Scholar
  30. Ellies M, Rohrbach-Volland S, Arglebe C, Wilken B, Laskawi R, Hanefeld F (2002a) Successful management of drooling with botulinum toxin A in neurologically disabled children. Neuropediatrics 33:327–330CrossRefPubMedGoogle Scholar
  31. Ellies M, Laskawi R, Rohrbach-Volland S, Arglebe C, Beuche W (2002b) Botulinum toxin to reduce saliva flow: selected indications for ultrasound-guided toxin application into salivary glands. Laryngoscope 112:82–86CrossRefPubMedGoogle Scholar
  32. Feussner H, Schröter-Morasch H (2014) Chirurgische Interventionen bei Schluckstörungen. In: Bartolome G, Schröter-Morasch H (eds) Schluckstörungen—Diagnostik und Rehabilitation, 5th edn. Elsevier, München, pp 493–517Google Scholar
  33. Fischbacher L, Schröter-Morasch H (2003) Medikamentöse Speichelreduktion bei Neurogener Dysphagie. In: Gross M, Kruse E (eds) Aktuelle phoniatrische-pädaudiologische Aspekte 2003/2004, Band 11. Medicombooks.de im Verlag videel, NiebüllGoogle Scholar
  34. Formeister EJ, Dahl JP, Rose AS (2014) Surgical management of chronic sialorrhea in pediatric patients: 10-year experience from one tertiary care institution. Int J Pediatr Otorhinolaryngol 78:1387–1392CrossRefPubMedGoogle Scholar
  35. Groß M (2017) Sekretretention. In: Keller S (ed) Außerklinische Intensivpflege. Elsevier, München, p p365Google Scholar
  36. Guidubaldi A, Fasano A, Ialongo T, Piano C, Pompili M, Mascianà R, Siciliani L, Sabatelli M, Bentivoglio AR (2011) Botulinum toxin A versus B in sialorrhea: a prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson’s disease. Mov Disord 26:313–319CrossRefPubMedGoogle Scholar
  37. Hawkey NM, Zaorsky NG, Galloway TJ (2016) The role of radiation therapy in the management of sialorrhea: a systematic review. Laryngoscope 126:80–85CrossRefPubMedGoogle Scholar
  38. Hinchey JA, Shephard T, Furie K, Smith D, Wang D, Tonn S, Stroke practice improvement network investigators (2005) Formal dysphagia screening protocols prevent pneumonia. Stroke 36:1972–1976CrossRefPubMedGoogle Scholar
  39. Holzapfel K (2014) Radiologische Diagnostik von Schluckstörungen. In: Bartolome G, Schröter-Morasch H (eds) Schluckstörungen—Diagnostik und Rehabilitation, 5th edn. Elsevier, München, pp 123–151Google Scholar
  40. Hussein I, Kershaw AE, Tahmassebi JF, Fayle SA (1998) The management of drooling in children and patients with mental and physical disabilities: a literature review. Int J Paediatr Dent 8:3–11CrossRefPubMedGoogle Scholar
  41. Hyson HC, Johnson AM, Jog MS (2002) Sublingual atropine for sialorrhea secondary to parkinsonism: a pilot study. Mov Disord 17:1318–1320CrossRefPubMedGoogle Scholar
  42. Jost WH (2016) The option of sonographic guidance in botulinum toxin injection for drooling in Parkinson’s disease. J Neural Transm 123:51–55CrossRefPubMedGoogle Scholar
  43. Jost WH, Friedman A, Michel O, Flatau-Baqué, Csikós J, Blitzer A (2019) SIAXI: Placebo-controlled, randomized, double-blind study of incobotulinumtoxinA for sialorrhea. Neurology.  https://doi.org/10.1212/WNL.0000000000007368 (Epub ahead of print)
  44. Kahl KG, Hagenah J, Zapf S, Trillenberg P, Klein C, Lencer R (2004) Botulinum toxin as an effective treatment of clozapine-induced hypersalivation. Psychopharmacology 173:229–230CrossRefPubMedGoogle Scholar
  45. Kahl KG, Trillenberg P, Kordon A, Lencer R, Klein C, Hagenah J (2005) Pharmacological strategies for clozapine-induced hypersalivation: treatment with botulinum toxin B in one patient and review of the literature. Nervenarzt 76:205–208CrossRefPubMedGoogle Scholar
  46. Katona G, Csákányi Z, Lorincz A, Gerlinger I (2008) Bilateral submandibular duct relocation by high-frequency radiosurgery. Eur Arch Otorhinolaryngol 265:1103–1108CrossRefPubMedGoogle Scholar
  47. Kok SE, van der Burg JJ, van Hulst K, Erasmus CE, van den Hoogen FJ (2016) The impact of submandibular duct relocation on drooling and the well-being of children with neurodevelopmental disabilities. Int J Pediatr Otorhinolaryngol 88:173–178CrossRefPubMedGoogle Scholar
  48. Lagalla G, Millevolte M, Capecci M, Provinciali L, Ceravolo MG (2009) Long-lasting benefits of botulinum toxin type B in Parkinson‘s disease-related drooling. Ceravolo MG. J Neurol 256:563–667CrossRefPubMedGoogle Scholar
  49. Lakraj AA, Moghimi N, Jabbari B (2013) Sialorrhea: anatomy, pathophysiology and treatment with emphasis on the role of botulinum toxins. Toxins (Basel) 5:1010–1031CrossRefGoogle Scholar
  50. Langmore SE, Schatz K, Olsen N (1988) Fiberoptic endoscopic examination of swallowing safety: a new procedure. Dysphagia 2:216–219CrossRefPubMedGoogle Scholar
  51. Laskawi R, Winterhoff J, Köhler S, Kottwitz L, Matthias C (2013) Botulinum toxin treatment of salivary fistulas following parotidectomy: follow-up results. Oral Maxillofac Surg 17:281–285CrossRefPubMedGoogle Scholar
  52. Lawson G, Remacle M (2006) Endoscopic cricopharyngeal myotomy: indications and technique. Curr Opin Otolaryngol Head Neck Surg 14:437–441CrossRefPubMedGoogle Scholar
  53. Lee ZI, Yu KJ, Lee DH, Hong SK, Woo SB, Kim JM, Park D (2017) The effect of nebulized glycopyrrolate on posterior Drooling in patients with brain injury: two cases of different brain lesions. Am J Phys Med Rehabil 96:e155–e158CrossRefPubMedGoogle Scholar
  54. Leung JG, Schak KM (2017) Potential problems surrounding the use of sublingually administered ophthalmic atropine for sialorrhea. Schizophr Res 185:202–203CrossRefPubMedGoogle Scholar
  55. Lim M, Mace A, Nouraei SA, Sandhu G (2006) Botulinum toxin in the management of sialorrhoea: a systematic review. Clin Otolaryngol 31:267–272CrossRefPubMedGoogle Scholar
  56. Limbrock J, Mundmotorik (2017) Empfehlungen für Babys und Kleinkinder mit Störungen der oralen Funktion. Osteopat Medizin 18:38–41CrossRefGoogle Scholar
  57. Limbrock GJ, Hoyer H, Scheying H (1990) Drooling, chewing and swallowing dysfunctions in children with cerebral palsy: treatment according to Castillo-Morales. ASDC J Dent Child 57:445–451PubMedGoogle Scholar
  58. Logemann JA (1997) Evaluation and treatment of swallowing disorders. Pro-Ed, AustinGoogle Scholar
  59. Man WH, Colen-de Koning JC, Schulte PF, Cahn W, van Haelst IM, Doodeman HJ, Egberts TC, Heerdink ER, Wilting I (2017) The effect of glycopyrrolate on nocturnal sialorrhea in patients using clozapine: a randomized, crossover, double-blind, placebo-controlled trial. J Clin Psychopharmacol 37:155–161CrossRefPubMedGoogle Scholar
  60. Mankarious LA, Bottrill ID, Huchzermeyer PM, Bailey CM (1999) Long-term follow-up of submandibular duct rerouting for the treatment of sialorrhea in the pediatric population. Otolaryngol Head Neck Surg 120:303–307CrossRefPubMedGoogle Scholar
  61. Marinone S, Gaynor W, Johnston J, Mahadevan M (2017) Castillo morales appliance therapy in the treatment of drooling children. Int J Pediatr Otorhinolaryngol 103:129–132CrossRefPubMedGoogle Scholar
  62. Martin TJ, Conley SF (2007) Long-term efficacy of intra-oral surgery for sialorrhea. Otolaryngol Head Neck Surg 137:54–58CrossRefPubMedGoogle Scholar
  63. Matos Santana TE, Capurso NA, Ranganathan M, Yoon G (2017) Sublingual atropine in the treatment of clozapine-induced sialorrhea. Schizophr Res 182:144–145CrossRefPubMedGoogle Scholar
  64. Mier RJ, Bachrach SJ, Lakin RC, Barker T, Childs J, Moran M (2000) Treatment of sialorrhea with glycopyrrolate: a double-blind, dose-ranging study. Arch Pediatr Adolesc Med 154:1214–1218CrossRefPubMedGoogle Scholar
  65. Mikami DLY, Furia CLB, Welker AF (2017) Addition of Kinesio Taping of the orbicularis oris muscles to speech therapy rapidly improves drooling in children with neurological disorders. Dev Neurorehabil 21:1–6Google Scholar
  66. Murray J, Langmore SE, Ginsberg S, Dostie A (1996) The significance of accumulated oropharyngeal secretions and swallowing frequency in predicting aspiration. Dysphagia 11:99–103CrossRefPubMedGoogle Scholar
  67. Neppelberg E, Haugen DF, Thorsen L, Tysnes OB (2007) Radiotherapy reduces sialorrhea in amyotrophic lateral sclerosis. Eur J Neurol 14:1373–1377CrossRefPubMedGoogle Scholar
  68. Neubauer PD, Rademaker AW, Leder SB (2015) The yale pharyngeal residue severity rating scale: an anatomically defined and image-based tool. Dysphagia 30:521–528CrossRefPubMedGoogle Scholar
  69. Noonan K, Prunty S, Ha JF, Vijayasekaran S (2014) Surgical management of chronic salivary aspiration. Int J Pediatr Otorhinolaryngol 78:2079–2082CrossRefPubMedGoogle Scholar
  70. Olthoff A, Carstens PO, Zhang S, von Fintel E, Friede T, Lotz J, Frahm J, Schmidt J (2016a) Evaluation of dysphagia by novel real-time MRI. Neurology 87:2132–2138CrossRefPubMedGoogle Scholar
  71. Olthoff A, Joseph AA, Weidenmüller M, Riley B, Frahm J (2016b) Real-time MRI of swallowing: intraoral pressure reduction supports larynx elevation. NMR Biomed 29:1618–1623CrossRefPubMedGoogle Scholar
  72. Ondo WG, Hunter C, Moore W (2004) A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson’s disease. Neurology 62:37–40CrossRefPubMedGoogle Scholar
  73. Parr JR, Weldon E, Pennington L, Steen N, Williams J, Fairhurst C, O’Hare A, Lodh R, Colver A (2014) The drooling reduction intervention trial (DRI): a single blind trial comparing the efficacy of glycopyrronium and hyoscine on drooling in children with neurodisability. Trials 15:60CrossRefPubMedPubMedCentralGoogle Scholar
  74. Postma AG, Heesters M, van Laar T (2007) Radiotherapy to the salivary glands as treatment of sialorrhea in patients with parkinsonism. Mov Disord 22:2430–2435CrossRefPubMedGoogle Scholar
  75. Praharaj SK, Munoli RN, Sharma PS (2014) Low-dose glycopyrrolate for clozapine-associated sialorrhea. J Clin Psychopharmacol 34:392CrossRefPubMedGoogle Scholar
  76. Prosiegel M, Buchholz D (2014) Mit Schluckstörungen assoziierte neurologische Erkrankungen. In: Bartolome G, Schröter-Morasch H (eds) Schluckstörungen—Diagnostik und Rehabilitation, 5th edn. Elsevier, München, pp 61–89Google Scholar
  77. Prosiegel M, Bartolome G, Biniek R, Fheodoroff K, Schlaegel W, Schröter-Morasch H, Steube D, Witte U. Saltuari U (2008) Rehabilitation neurogener Dysphagien. In: Diener HC (ed) Leitlinien für Diagnostik und Therapie in der Neurologie. Thieme, Stuttgart, pp 908–919Google Scholar
  78. Qurashi I, Chu S, Husain N, Drake RJ, Chaudhry I, Deakin JF (2016) Glycopyrrolate in comparison to hyoscine hydrobromide and placebo in the treatment of hypersalivation induced by clozapine (GOTHIC1): study protocol for a randomised controlled feasibility study. Trials 17:553CrossRefPubMedPubMedCentralGoogle Scholar
  79. Reed J, Mans CK, Brietzke SE (2009) Surgical management of drooling: a meta-analysis. Arch Otolaryngol Head Neck Surg 135:924–931CrossRefPubMedGoogle Scholar
  80. Reynolds J, Carroll S, Sturdivant C (2016) Fiberoptic endoscopic evaluation of swallowing: a multidisciplinary alternative for assessment of infants with dysphagia in the neonatal intensive care unit. Adv Neonatal Care 16:37–43CrossRefPubMedGoogle Scholar
  81. Rohrbach S, Gross M (2014) Die transnasale fiberoptisch-endoskopische Schluckuntersuchung (FEES) bei Kindern—Standardisiertes diagnostisches Vorgehen. Monatsschrift Kinderheilkunde 162:329–333CrossRefGoogle Scholar
  82. Rohrbach S, Laskawi R (2004) Praktische Anwendung von Botulinum-Toxin im Kopf—Hals-Bereich. HNO 52:635–641CrossRefPubMedGoogle Scholar
  83. Rosenbek JC, Robbins JA, Roecker EB (1996) A penetration-aspiration scale. Dysphagia 11:93–98CrossRefPubMedGoogle Scholar
  84. S3 Leitlinie Palliativmedizin (2015) https://www.leitlinienprogramm-onkologie.de/index.php?id=80&type=0. Accesed 31 July 2018
  85. Schroeder AS, Kling T, Huss K, Borggraefe I, Koerte IK, Blaschek A, Jahn K, Heinen F, Berweck S (2012) Botulinum toxin type A and B for the reduction of hypersalivation in children with neurological disorders: a focus on effectiveness and therapy adherence. Neuropediatrics 43:27–36CrossRefPubMedGoogle Scholar
  86. Schröter-Morasch H, Graf S (2014) Dysphagiediagnostik durch den HNO-Arzt. HNO 62:324–334CrossRefPubMedGoogle Scholar
  87. Seegenschmiedt MH, Makoski HB, Trott KR, Brady LW (2008) Sialorrhea/Hypersalivation. In: Seegenschmiedt MH, Makoski HB, Trott KR, Brady LW (eds) Radiotherapy for non-malignant disorders. Springer, Berlin, pp 573–579CrossRefGoogle Scholar
  88. Sittironnarit G, Ames D, Bush AI, Faux N, Flicker L, Foster J, Hilmer S, Lautenschlager NT, Maruff P, Masters CL, Martins RN, Rowe C, Szoeke C, Ellis KA, AIBL research group (2011) Effects of anticholinergic drugs on cognitive function in older Australians: results from the AIBL study. Dement Geriatr Cogn Disord 31:173–178CrossRefPubMedGoogle Scholar
  89. Squires N, Humberstone M, Wills A, Arthur A (2014) The use of botulinum toxin injections to manage drooling in amyotrophic lateral sclerosis/motor neurone disease: a systematic review. Dysphagia 29:500–508CrossRefPubMedGoogle Scholar
  90. Steffen A, Ortfeld S, Schönweiler R (2011a) Drooling bei neuropädiatrischen Patienten—ein Update. Klin Padiatr 223:5–9CrossRefPubMedGoogle Scholar
  91. Steffen A, Wollenberg B, Schönweiler R, Brüggemann N, Meyners T (2011b) Drooling nach Strahlentherapie—Botulinumtoxin als erfolgreiches Therapieverfahren. HNO 59:115–117CrossRefPubMedGoogle Scholar
  92. Steffen A, Beutner D, Hakim S, Jost W, Kahl KG, Laskawi R, Lencer R, Mall V, Mehrhoff FW, Meyners T, Schönweiler R, Schröder S, Schröter-Morasch H, Schuster M, Steinlechner S, Winterhoff J, Zenk J, Lichius O, AWMF (2013) Hypersalivation—inauguration of the S2k guideline (AWMF) in short form. Laryngorhinootologie 92:515–522CrossRefPubMedGoogle Scholar
  93. Steffen A, Hasselbacher K, Heinrichs S, Wollenberg B (2014) Botulinum toxin for salivary disorders in the treatment of head and neck cancer. Anticancer Res 34:6627–6632PubMedGoogle Scholar
  94. Steffen A, Hasselbacher K, Brüggemann N, Heinrichs S, Schönweiler R, Wollenberg B (2015) Botulinumtoxin bei funktioneller hypersalivation—alles eine Frage der Dosis? Laryngorhinootologie 94:378–382PubMedGoogle Scholar
  95. Steinlechner S, Klein C, Moser A, Lencer R, Hagenah J (2010) Botulinum toxin B as an effective and safe treatment for neuroleptic-induced sialorrhea. Psychopharmacology 207:593–597CrossRefPubMedGoogle Scholar
  96. Stone CA, N O‘Leary (2009) Systematic review of the effectiveness of botulinum toxin or radiotherapy for sialorrhea in patients with amyotrophic lateral sclerosis. J Pain Symptom Manag 37:246–258CrossRefGoogle Scholar
  97. Suntrup S, Marian T, Schröder JB, Suttrup I, Muhle P, Oelenberg S, Hamacher C, Minnerup J, Warnecke T, Dziewas R (2015) Electrical pharyngeal stimulation for dysphagia treatment in tracheotomized stroke patients: a randomized controlled trial. Intensive Care Med 41:1629–1637CrossRefPubMedGoogle Scholar
  98. Thomas-Stonell N, Greenberg J (1988) Three treatment approaches and clinical factors in the reduction of drooling. Dysphagia 3:73–78CrossRefPubMedGoogle Scholar
  99. Uppal HS, De R, D’Souza AR, Pearman K, Proops DW (2003) Bilateral submandibular duct relocation for drooling: an evaluation of results for the Birmingham Children’s Hospital. Eur Arch Otorhinolaryngol 260:48–51CrossRefPubMedGoogle Scholar
  100. van Hulst K, van den Engel-Hoek L, Geurts ACH, Jongerius PH, van der Burg JJW, Feuth T, van den Hoogen FJA, Erasmus CE (2018) Development of the drooling infants and preschoolers scale (DRIPS) and reference charts for monitoring saliva control in children aged 0–4 years. Infant Behav Dev 50:247–256CrossRefPubMedGoogle Scholar
  101. Vashishta R, Nguyen SA, White DR, Gillespie MB (2013) Botulinum toxin for the treatment of sialorrhea: a meta-analysis. Otolaryngol Head Neck Surg 148:191–196CrossRefPubMedGoogle Scholar
  102. Verma R, Anand KS (2017) Botulinum toxin: a novel therapy for clozapine-induced sialorrhoea. Psychopharmacology 235:369–371CrossRefPubMedGoogle Scholar
  103. Weikamp JG, Schinagl DA, Verstappen CC, Schelhaas HJ, de Swart BJ, Kalf JG (2016) Botuninum toxin-A injections vs. radiotherapy for drooling in ALS. Acta Neurol Scand 134:224–231CrossRefPubMedGoogle Scholar
  104. Wildiers H, Dhaenekint C, Demeulenaere P, Clement PM, Desmet M, Van Nuffelen R, Gielen J, Van Droogenbroeck E, Geurs F, Lobelle JP, Menten J, Flemish Federation of Palliative Care (2009) Atropine, hyoscine butylbromide, or scopolamine are equally effective for the treatment of death rattle in terminal care. J Pain Symptom Manage 38:124–133CrossRefPubMedGoogle Scholar
  105. Wilken B, Aslami B, Backes H (2008) Successful treatment of drooling in children with neurological disorders with botulinum toxin A or B. Neuropediatrics 39:200–204CrossRefPubMedGoogle Scholar
  106. Wu KP, Ke JY, Chen CY, Chen CL, Chou MY, Pei YC (2011) Botulinum toxin type A on oral health in treating sialorrhea in children with cerebral palsy: a randomized, double-blind, placebo-controlled study. J Child Neurol 26:838–843CrossRefPubMedGoogle Scholar
  107. Zeller RS, Davidson J, Lee HM, Cavanaugh PF (2012a) Safety and efficacy of glycopyrrolate oral solution for management of pathologic drooling in pediatric patients with cerebral palsy and other neurologic conditions. Ther Clin Risk Manag 8:25–32CrossRefPubMedPubMedCentralGoogle Scholar
  108. Zeller RS, Lee HM, Cavanaugh PF, Davidson J (2012b) Randomized phase III evaluation of the efficacy and safety of a novel glycopyrrolate oral solution for the management of chronic severe drooling in children with cerebral palsy or other neurologic conditions. Ther Clin Risk Manag 8:15–23CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag GmbH Austria, part of Springer Nature 2019

Authors and Affiliations

  • Armin Steffen
    • 1
    Email author
  • Wolfgang Jost
    • 1
  • Tobias Bäumer
    • 1
  • Dirk Beutner
    • 1
  • Sabine Degenkolb-Weyers
    • 1
  • Martin Groß
    • 1
  • Maria Grosheva
    • 1
  • Samer Hakim
    • 1
  • Kai G. Kahl
    • 1
  • Rainer Laskawi
    • 1
  • Rebekka Lencer
    • 1
  • Jan Löhler
    • 1
  • Thekla Meyners
    • 1
  • Saskia Rohrbach-Volland
    • 1
  • Rainer Schönweiler
    • 1
  • Sara-Christina Schröder
    • 1
  • Sebastian Schröder
    • 1
  • Heidrun Schröter-Morasch
    • 1
  • Maria Schuster
    • 1
  • Susanne Steinlechner
    • 1
  • Roland Urban
    • 1
  • Orlando Guntinas-Lichius
    • 1
  1. 1.Department for OtorhinolaryngologyUniversity of LuebeckLübeckGermany

Personalised recommendations